doi:10.1016/j.cell.2017.02.031
10.1016/j.vph.2018.02.010 [DOI] [PubMed] [Google Scholar] Vukojevic J., Vrdoljak B., Malekinusic D., Siroglavic M., Milavic M., Kolenc D., et al
Administration Protocols: Best Practices for Research Subjects In preclinical research, the most common route of administration for peptides like SLU-PP-332 is subcutaneous (Sub-Q) injection
For long-term or large-animal studies, BPC-157 10 mg gives you the flexibility to explore extended outcomes
The most consistently recommended practical step, across the community discussion of this topic, is starting at a reduced frequency rather than daily use from the outset: two to three applications a week for the first couple of weeks, building up to daily use gradually rather than all at once